Sign Up Today and Learn More About Orna Therapeutics Stock
Invest in or calculate the value of your shares in Orna Therapeutics or other pre-IPO companies through EquityZen's platform.
Orna Therapeutics Stock (ORNT)
Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.
About Orna Therapeutics Stock
Founded
2019
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Orna Therapeutics Press Mentions
Stay in the know about the latest news on Orna Therapeutics
North America Q1 Funding Surges Across Stages To Record Level
news • Apr 06, 2026
Eli Lilly outlays $7.8bn to acquire sleep drug biotech Centessa
pharmaceutical-technology • Apr 02, 2026
With Zepbound approved for sleep apnea, Lilly spends up to $7.8 billion for a company with a narcolepsy drug
morningstar • Apr 01, 2026
Data: OpenAI Has Already Done Nearly As Many M&A Deals In 2026 As It Did All of Last Year
news • Mar 25, 2026
Why You Haven’t Raised Startup Funding (Yet)
news • Mar 23, 2026
Orna Therapeutics Management
Leadership team at Orna Therapeutics
Founder & Director, Molecular Biology
Alex Wesselhoeft
Founder, Director of Business Development & Former Board Director
Raffaella Squilloni
Join now and verify your accreditation status to gain access to:
- Orna Therapeutics Current Valuation
- Orna Therapeutics Stock Price
- Orna Therapeutics Management
- Available deals in Orna Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Orna Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Orna Therapeutics Revenue and Financials
- Orna Therapeutics Highlights
- Orna Therapeutics Business Model
- Orna Therapeutics Risk Factors
- Orna Therapeutics Research Report from SACRA Research
Trading Orna Therapeutics Stock
How to invest in Orna Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Orna Therapeutics through EquityZen funds. These investments are made available by existing Orna Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Orna Therapeutics stock?
Shareholders can sell their Orna Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
